<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr="http://purl.org/syndication/thread/1.0" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><atom:id>tag:blogger.com,1999:blog-4697350873058183760</atom:id><lastBuildDate>Wed, 02 May 2012 00:02:13 +0000</lastBuildDate><category>DMARD</category><category>Enbrel</category><category>cancer</category><category>cardiovascular</category><category>Cost</category><category>Erasmus</category><category>funding</category><category>TNF Blockers</category><category>Adalimumab</category><category>Arthritis Foundation</category><category>Pharmaceutical Companies</category><category>Juvenile Arthritis</category><category>Bilogics</category><category>Keneret</category><category>CHAT</category><category>SABIO</category><category>Tumor Necrosis Factor (TNF)</category><category>Ankylosing spondylitis</category><category>Discovery</category><category>RA</category><category>Atrhritis</category><category>PMB</category><category>PHANGO</category><category>Heart Risks</category><category>patch; biologics</category><category>heart attack</category><category>RA Algorithm</category><category>Rheumatoid Arthritis</category><category>Medical Schemes</category><category>Side Effects</category><category>Etanercept</category><category>Annals of the Rheumatic Diseases</category><category>Psoriasis</category><category>Infliximab</category><category>BWG</category><category>Humira</category><category>methotrexate</category><category>stroke</category><category>Mapthera</category><category>Rituxan</category><category>Revelex</category><category>Cytokines</category><category>Psoriatic Arthritis</category><category>Biologics</category><category>Biologics Working Group</category><title>Biologics</title><description>In recent years, there have been promising advances in treating rheumatoid arthritis -- especially for those people who do not respond to disease-modifying drugs. The most important advance has been the development of a group of drugs called biologic response modifiers or biologics. This site has been established as a mouthpiece to the arthritis sufferer; providing regular updates of trends on biologics and developments on the availability thereof in Southern Africa.</description><link>http://www.biologics.co.za/</link><managingEditor>noreply@blogger.com (Andre Augustyn)</managingEditor><generator>Blogger</generator><openSearch:totalResults>16</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/Biologics" /><feedburner:info uri="biologics" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-9114737893207458560</guid><pubDate>Wed, 31 Aug 2011 09:20:00 +0000</pubDate><atom:updated>2011-08-31T11:20:44.118+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Psoriatic Arthritis</category><category domain="http://www.blogger.com/atom/ns#">Psoriasis</category><category domain="http://www.blogger.com/atom/ns#">Heart Risks</category><title>Psoriasis Drugs Not Linked To Increased Heart Risks: Study</title><atom:summary>Source: http://www.huffingtonpost.com/2011/08/24/psoriasis-drugs-heart-risks-biologics_n_935462.html  						                                                      															 									 	 	   																	 								 							  							  																											
For people with severe cases of psoriasis, the injectable drugs known  as biologics can provide much-needed relief from the itchy, </atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/it8dxK5BBtw/psoriasis-drugs-not-linked-to-increased.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/-lQNdrf7B8jg/Tl38rL-jxoI/AAAAAAAAAGE/fjMA1yTlK1s/s72-c/psoriasis-arthritis-hands-400x400.jpg" height="72" width="72" /><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/it8dxK5BBtw" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2011/08/psoriasis-drugs-not-linked-to-increased.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-1298620476988826962</guid><pubDate>Wed, 31 Aug 2011 09:12:00 +0000</pubDate><atom:updated>2011-08-31T11:12:18.018+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">RA</category><category domain="http://www.blogger.com/atom/ns#">Biologics</category><category domain="http://www.blogger.com/atom/ns#">Rheumatoid Arthritis</category><title>RA patients "wait seven years before getting biologics"</title><atom:summary>              World News | August 30, 2011   Lynne Taylor
                 
  
 
Patients  wait 18 months after first experiencing any symptoms of rheumatoid  arthritis (RA) before going to see their doctor, and they wait an  average of seven years before their doctor starts treating with them a  biologic drug, says a new study.
 This is despite  findings which show that patients who are being </atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/GOylZLf5Nh0/ra-patients-wait-seven-years-before.html</link><author>noreply@blogger.com (Andre Augustyn)</author><thr:total>1</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/GOylZLf5Nh0" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2011/08/ra-patients-wait-seven-years-before.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-4498762547580729960</guid><pubDate>Fri, 05 Aug 2011 07:18:00 +0000</pubDate><atom:updated>2011-08-05T09:19:22.322+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">patch; biologics</category><title>Patch may replace IV drug infusions</title><atom:summary>July 11, 2011|By Lindsey Hoshaw, Globe Correspondent
Frank Bobe, SpringLeaf chief executive, said the device gives control… (Jonathan Wiggs/Globe Staff)
Patients who receive frequent intravenous injections to treat chronic illness typically endure arduous hospital visits. A new device could change that. SpringLeaf Therapeutics is developing a drug-filled patch patients can attach to their skin to</atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/PEa4mw8HVfA/patch-may-replace-iv-drug-infusions.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/-zu7j6nfbDsU/TjuYOO5MTRI/AAAAAAAAAGA/6SRocDiADHk/s72-c/11patch_photo1__688x806.jpg" height="72" width="72" /><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/PEa4mw8HVfA" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2011/08/patch-may-replace-iv-drug-infusions.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-7227277595287253563</guid><pubDate>Wed, 25 May 2011 11:46:00 +0000</pubDate><atom:updated>2011-05-25T13:46:17.644+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Bilogics</category><category domain="http://www.blogger.com/atom/ns#">Atrhritis</category><title>Is It Time to Take Biologics?</title><atom:summary>If you suffer from chronic pain, you may have to try a variety of  treatments before you find the right ones for your symptoms. Some  treatments may include pain and anti-inflammatory medications, diet and  lifestyle changes, physical, occupational and support therapies. If  these don't provide the relief you need, there's one more option that  might relieve your chronic pain--biologics. 
</atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/7W-QzaN5IGU/is-it-time-to-take-biologics.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://4.bp.blogspot.com/-cVqcKUi-sGw/TdzrpV-KaCI/AAAAAAAAAFc/tbjmGVW-7JQ/s72-c/getty_rf_photo_of_biologic_treatment_for_psoriasis.jpg" height="72" width="72" /><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/7W-QzaN5IGU" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2011/05/is-it-time-to-take-biologics.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-1438316016204482777</guid><pubDate>Mon, 21 Dec 2009 13:04:00 +0000</pubDate><atom:updated>2009-12-21T16:18:23.122+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Psoriatic Arthritis</category><category domain="http://www.blogger.com/atom/ns#">Biologics</category><category domain="http://www.blogger.com/atom/ns#">Ankylosing spondylitis</category><category domain="http://www.blogger.com/atom/ns#">PMB</category><category domain="http://www.blogger.com/atom/ns#">Medical Schemes</category><category domain="http://www.blogger.com/atom/ns#">Rheumatoid Arthritis</category><title>Money or your life!</title><atom:summary>Despite the recent South African test case (Erasmus vs Discovery) resulting in the inclusion of biologics as the current treatment algorithm for Rheumatoid Arthritis, this does unfortunately not change the position for a large percentage individuals identified with other forms of arthritis.     As an individual suffering from severe psoriatic arthritis that has evolved to ankylosis spondylitis, </atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/MiEKs7H4nl4/despite-recent-south-african-test-case.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://1.bp.blogspot.com/_71b4S-emCj4/Sy-AHUiGb8I/AAAAAAAAAFA/kKA0dM9hx0M/s72-c/6180.jpg" height="72" width="72" /><thr:total>3</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/MiEKs7H4nl4" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2009/12/despite-recent-south-african-test-case.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-8872664671552645088</guid><pubDate>Sun, 29 Nov 2009 15:36:00 +0000</pubDate><atom:updated>2009-11-29T17:48:41.295+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">RA Algorithm</category><category domain="http://www.blogger.com/atom/ns#">Discovery</category><category domain="http://www.blogger.com/atom/ns#">funding</category><category domain="http://www.blogger.com/atom/ns#">Biologics</category><category domain="http://www.blogger.com/atom/ns#">Medical Schemes</category><category domain="http://www.blogger.com/atom/ns#">Rheumatoid Arthritis</category><category domain="http://www.blogger.com/atom/ns#">Erasmus</category><title>Full funding for arthritis now possible in SA</title><atom:summary> Full funding of biologic drugs for medical scheme members with severe rheumatoid arthritis (RA) is now a reality.In a surprising about turn, Discovery recently retracted their second appeal against two earlier rulings by the Council for Medical Schemes, which ordered them to fund their member, Sylvia Erasmus[1], in full for the use of the anti-rheumatic biologic, Enbrel, after previous treatment</atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/YOVtH4-TPW4/full-funding-for-arthritis-biologics.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://4.bp.blogspot.com/_71b4S-emCj4/SxKWsYKKGeI/AAAAAAAAAEw/SnX-N6zayi8/s72-c/ASP%2520for%2520Biologics.jpg" height="72" width="72" /><thr:total>2</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/YOVtH4-TPW4" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2009/11/full-funding-for-arthritis-biologics.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-3499250972984702994</guid><pubDate>Wed, 29 Oct 2008 09:12:00 +0000</pubDate><atom:updated>2008-10-29T11:25:28.261+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">TNF Blockers</category><category domain="http://www.blogger.com/atom/ns#">Rheumatoid Arthritis</category><category domain="http://www.blogger.com/atom/ns#">cancer</category><title>Biologics Don't raise cancer risk in RA Patients</title><atom:summary>TNF-antagonists, drugs widely used to treat rheumatoid arthritis (RA), don't appear to cause cancer, say Spanish researchers who analyzed data on more than 4,000 RA patients treated with the biologics. These drugs, which have been used since 1998 and given to more than 600,000 people worldwide, interfere with biologic substances that cause or worsen inflammation in RA patients. But it's been </atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/zOx5VPchDLs/biologics-dont-raise-cancer-risk-in-ra.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/_71b4S-emCj4/SQgq75rAAWI/AAAAAAAAADM/6A57i3FYj0Y/s72-c/sitting.gif" height="72" width="72" /><thr:total>1</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/zOx5VPchDLs" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2008/10/biologics-dont-raise-cancer-risk-in-ra.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-2826390598346800357</guid><pubDate>Thu, 06 Mar 2008 09:24:00 +0000</pubDate><atom:updated>2008-03-06T11:35:14.553+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">RA</category><category domain="http://www.blogger.com/atom/ns#">heart attack</category><category domain="http://www.blogger.com/atom/ns#">TNF Blockers</category><category domain="http://www.blogger.com/atom/ns#">cardiovascular</category><category domain="http://www.blogger.com/atom/ns#">stroke</category><category domain="http://www.blogger.com/atom/ns#">Rheumatoid Arthritis</category><category domain="http://www.blogger.com/atom/ns#">methotrexate</category><title>Arthritis medications reduce the risk of heart attacks and strokes</title><atom:summary>Patients prescribed drugs to treat rheumatoid arthritis could be at a reduced risk of heart attacks and strokes, according to a study published today in the open access journal Arthritis Research &amp; Therapy.An international team of researchers led by Antonio Naranjo of the University of Las Palmas de Gran Canaria, Spain, and colleagues in Argentina, Europe, and the USA have analyzed data from the </atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/HX70891OPkE/arthritis-medications-reduce-risk-of.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_71b4S-emCj4/R8-57em0ZOI/AAAAAAAAAC8/PiMsr1a4QUo/s72-c/heart-and-stethescope.jpg" height="72" width="72" /><thr:total>4</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/HX70891OPkE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2008/03/arthritis-medications-reduce-risk-of.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-2317609099482447591</guid><pubDate>Mon, 03 Sep 2007 07:01:00 +0000</pubDate><atom:updated>2007-09-03T09:25:15.574+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Infliximab</category><category domain="http://www.blogger.com/atom/ns#">Adalimumab</category><category domain="http://www.blogger.com/atom/ns#">Etanercept</category><category domain="http://www.blogger.com/atom/ns#">Annals of the Rheumatic Diseases</category><category domain="http://www.blogger.com/atom/ns#">Tumor Necrosis Factor (TNF)</category><title>Drug switch may benefit arthritis patients</title><atom:summary>NEW YORK (Reuters Health) - Patients with rheumatoid arthritis who fail to respond to one of the biological drugs will often have a better response to a second drug within the same class, Danish researchers report in the Annals of the Rheumatic Diseases."Our data show that patients with rheumatoid arthritis benefit from switching to a second biologic drug," lead investigator Dr. Elisabeth Hjardem</atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/tPDtpW_U1NI/drug-switch-may-benefit-arthritis.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://1.bp.blogspot.com/_71b4S-emCj4/Rtu2ojG1LTI/AAAAAAAAAC0/63VsDJ3EDFs/s72-c/Hypothesis.gif" height="72" width="72" /><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/tPDtpW_U1NI" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2007/09/drug-switch-may-benefit-arthritis.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-4441517422874013082</guid><pubDate>Wed, 22 Aug 2007 12:04:00 +0000</pubDate><atom:updated>2007-08-22T14:17:47.187+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Pharmaceutical Companies</category><category domain="http://www.blogger.com/atom/ns#">Cost</category><category domain="http://www.blogger.com/atom/ns#">Psoriatic Arthritis</category><category domain="http://www.blogger.com/atom/ns#">Juvenile Arthritis</category><category domain="http://www.blogger.com/atom/ns#">Biologics</category><category domain="http://www.blogger.com/atom/ns#">Ankylosing spondylitis</category><category domain="http://www.blogger.com/atom/ns#">Medical Schemes</category><category domain="http://www.blogger.com/atom/ns#">Rheumatoid Arthritis</category><title>Cost of Biologics - Who holds the answer?</title><atom:summary>Biologics, the new ‘wonder-drug’ in the fight against arthritis, offers the hope of partial or complete remission to people with previously incurable systemic arthritis diseases like rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and juvenile arthritis. But there is no getting around the fact that biologics are very expensive, typically costing 20 times more per patient per day</atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/_jE0ol0BCYQ/cost-of-biologics-what-holds-answer.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://1.bp.blogspot.com/_71b4S-emCj4/Rswn9TG1LPI/AAAAAAAAACU/GVkO17pFLyM/s72-c/Dollar+small.jpg" height="72" width="72" /><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/_jE0ol0BCYQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2007/08/cost-of-biologics-what-holds-answer.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-2711879265322411049</guid><pubDate>Fri, 17 Aug 2007 11:14:00 +0000</pubDate><atom:updated>2007-08-17T09:44:59.836+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Humira</category><category domain="http://www.blogger.com/atom/ns#">Revelex</category><category domain="http://www.blogger.com/atom/ns#">Psoriatic Arthritis</category><category domain="http://www.blogger.com/atom/ns#">Enbrel</category><category domain="http://www.blogger.com/atom/ns#">Biologics</category><category domain="http://www.blogger.com/atom/ns#">Rheumatoid Arthritis</category><title>What is Biologics?</title><atom:summary>Biologics are genetically engineered proteins derived from human genes. They are designed to either inhibit or supplement specific components of the immune system called cytokines. These cytokines play a pivotal role in either fueling or suppressing inflammation (a key component in several forms of arthritis, such as rheumatoid arthritis and psoriatic arthritis).In recent years, there have been </atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/IUHeSAAuYnw/what-is-biologics.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://4.bp.blogspot.com/_71b4S-emCj4/RrL8oDynMvI/AAAAAAAAAA0/RymOpm7bECs/s72-c/bild_00023.jpg" height="72" width="72" /><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/IUHeSAAuYnw" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2007/07/what-is-biologics.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-7361794930122718003</guid><pubDate>Tue, 07 Aug 2007 07:37:00 +0000</pubDate><atom:updated>2007-08-17T09:45:20.554+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Biologics Working Group</category><category domain="http://www.blogger.com/atom/ns#">Medical Schemes</category><category domain="http://www.blogger.com/atom/ns#">BWG</category><title>The battle of profit vs health</title><atom:summary>Star Editorial (August 06, 2007 Edition 2)What price the milk of human kindness? That's a question we can ask in the wake of a study that challenges claims by medical aid schemes that highly effective biological drugs are too expensive to provide.Biologics are target-specific treatments - such as the breast cancer drug Herceptin - that attack particular cells, cannot be manufactured and are grown</atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/cOpTDcBvAzI/battle-of-profit-vs-health.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://4.bp.blogspot.com/_71b4S-emCj4/RsVQhzG1LHI/AAAAAAAAABU/2ShgmQahmLg/s72-c/site_header_1.gif" height="72" width="72" /><thr:total>1</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/cOpTDcBvAzI" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2007/08/battle-of-profit-vs-health.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-1224955873937972869</guid><pubDate>Sun, 29 Jul 2007 09:48:00 +0000</pubDate><atom:updated>2007-08-03T12:03:17.312+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Humira</category><category domain="http://www.blogger.com/atom/ns#">Revelex</category><category domain="http://www.blogger.com/atom/ns#">Mapthera</category><category domain="http://www.blogger.com/atom/ns#">TNF Blockers</category><category domain="http://www.blogger.com/atom/ns#">Enbrel</category><category domain="http://www.blogger.com/atom/ns#">Side Effects</category><category domain="http://www.blogger.com/atom/ns#">Keneret</category><category domain="http://www.blogger.com/atom/ns#">Rituxan</category><title>Tumor necrosis factor (TNF) blockers - Most commonly prescribed in South Africa</title><atom:summary>These biologic response modifiers block an immune system protein called tumor necrosis factor, which acts as an inflammatory agent in some types of arthritis. By targeting this protein, TNF blockers can help reduce pain, morning stiffness and swollen joints. Some people experience side effects during or shortly after these drugs are injected, including chest pain, dizziness and difficulty </atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/Xaqzmr5mQ00/tumor-necrosis-factor-tnf-blockers-most.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/_71b4S-emCj4/RrL7TjynMtI/AAAAAAAAAAk/oGIl7L_S1bE/s72-c/inflix2.jpg" height="72" width="72" /><thr:total>1</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/Xaqzmr5mQ00" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2007/07/tumor-necrosis-factor-tnf-blockers-most.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-2745894582499373672</guid><pubDate>Sun, 17 Jun 2007 06:42:00 +0000</pubDate><atom:updated>2007-08-17T09:30:12.972+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">DMARD</category><category domain="http://www.blogger.com/atom/ns#">Arthritis Foundation</category><category domain="http://www.blogger.com/atom/ns#">Juvenile Arthritis</category><category domain="http://www.blogger.com/atom/ns#">Biologics</category><category domain="http://www.blogger.com/atom/ns#">CHAT</category><title>Children's Arthritis Trust (CHAT)</title><atom:summary>Children's Arthritis Trust (CHAT) offers hope to kids crippled by arthritis.To help treatment resistant children and teenagers in public healthcare who have not responded to the conventional drugs used for treating this crippling and devastating illness, The Arthritis Foundation has launched a special Children's Arthritis Trust called CHAT (Children Have Arthritis Too). The funds raised by this </atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/zJUx_pom-l8/childrens-arthritis-trust-chat.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_71b4S-emCj4/RsVIyjG1LGI/AAAAAAAAABM/LZVu8SunBjw/s72-c/Arthritis_Young_Person_book_img1.gif" height="72" width="72" /><thr:total>2</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/zJUx_pom-l8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2007/05/childrens-arthritis-trust-chat.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-3848816303600777185</guid><pubDate>Thu, 07 Jun 2007 13:44:00 +0000</pubDate><atom:updated>2007-08-17T09:29:49.372+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">SABIO</category><category domain="http://www.blogger.com/atom/ns#">Arthritis Foundation</category><category domain="http://www.blogger.com/atom/ns#">Cytokines</category><category domain="http://www.blogger.com/atom/ns#">Biologics</category><category domain="http://www.blogger.com/atom/ns#">Rheumatoid Arthritis</category><title>RA drug too costly, say SA schemes</title><atom:summary>There is a revolutionary new arthritis drug on the market, but some South African medical schemes seem unwilling to pay for it.A ground-breaking new class of drugs, known as biologics, offers the hope of partial or complete remission to people with previously incurable systemic arthritis diseases like rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and juvenile arthritis.However</atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/DuonmSspTWc/ra-drug-too-costly-say-sa-schemes.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://1.bp.blogspot.com/_71b4S-emCj4/Rrh4FzynMxI/AAAAAAAAABE/XziLN5St5XY/s72-c/old_hands.jpg" height="72" width="72" /><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/DuonmSspTWc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2007/05/ra-drug-too-costly-say-sa-schemes.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-4697350873058183760.post-6085975324184053899</guid><pubDate>Sun, 06 May 2007 14:10:00 +0000</pubDate><atom:updated>2007-08-06T16:28:41.042+02:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">SABIO</category><category domain="http://www.blogger.com/atom/ns#">Arthritis Foundation</category><category domain="http://www.blogger.com/atom/ns#">PHANGO</category><category domain="http://www.blogger.com/atom/ns#">Juvenile Arthritis</category><category domain="http://www.blogger.com/atom/ns#">Biologics</category><title>People with arthritis - giving voice to your concerns</title><atom:summary> "The Arthritis Foundation has taken up the challenge to ensure that people with arthritis will no longer be ignored when political or medical decisions are being taken that affect us." For too long we have merely accepted the word of our doctors, the ruling of our medical aids, or the service we get in the public health facilities, believing that one little lone voice won't achieve much in the </atom:summary><link>http://feedproxy.google.com/~r/Biologics/~3/7ImqpyuXwTA/people-with-arthritis-giving-voice-to.html</link><author>noreply@blogger.com (Andre Augustyn)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://4.bp.blogspot.com/_71b4S-emCj4/RrcsRzynMwI/AAAAAAAAAA8/afe51ZY2uqg/s72-c/af_slogan.jpg" height="72" width="72" /><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/Biologics/~4/7ImqpyuXwTA" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.biologics.co.za/2007/05/people-with-arthritis-giving-voice-to.html</feedburner:origLink></item></channel></rss>

